GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » Cyclically Adjusted Revenue per Share

Eckert & Ziegler SE (XTER:EUZ) Cyclically Adjusted Revenue per Share : €10.01 (As of Sep. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Eckert & Ziegler SE Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Eckert & Ziegler SE's adjusted revenue per share for the three months ended in Sep. 2024 was €3.362. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €10.01 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Eckert & Ziegler SE's average Cyclically Adjusted Revenue Growth Rate was 8.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Eckert & Ziegler SE was 10.20% per year. The lowest was 3.70% per year. And the median was 6.55% per year.

As of today (2025-01-19), Eckert & Ziegler SE's current stock price is €48.24. Eckert & Ziegler SE's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was €10.01. Eckert & Ziegler SE's Cyclically Adjusted PS Ratio of today is 4.82.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Eckert & Ziegler SE was 16.97. The lowest was 1.23. And the median was 4.33.


Eckert & Ziegler SE Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Eckert & Ziegler SE's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE Cyclically Adjusted Revenue per Share Chart

Eckert & Ziegler SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.74 6.97 7.53 8.54 9.34

Eckert & Ziegler SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.26 9.34 9.58 9.83 10.01

Competitive Comparison of Eckert & Ziegler SE's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Eckert & Ziegler SE's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eckert & Ziegler SE's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's Cyclically Adjusted PS Ratio falls into.



Eckert & Ziegler SE Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eckert & Ziegler SE's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=3.362/126.1978*126.1978
=3.362

Current CPI (Sep. 2024) = 126.1978.

Eckert & Ziegler SE Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 1.641 99.543 2.080
201503 1.602 99.717 2.027
201506 1.654 100.417 2.079
201509 1.592 100.417 2.001
201512 1.763 99.717 2.231
201603 1.693 100.017 2.136
201606 1.186 100.717 1.486
201609 1.351 101.017 1.688
201612 1.437 101.217 1.792
201703 1.551 101.417 1.930
201706 1.514 102.117 1.871
201709 1.683 102.717 2.068
201712 1.806 102.617 2.221
201803 1.690 102.917 2.072
201806 2.158 104.017 2.618
201809 2.107 104.718 2.539
201812 2.217 104.217 2.685
201903 2.127 104.217 2.576
201906 2.206 105.718 2.633
201909 2.144 106.018 2.552
201912 2.201 105.818 2.625
202003 2.160 105.718 2.578
202006 1.901 106.618 2.250
202009 2.102 105.818 2.507
202012 2.366 105.518 2.830
202103 2.145 107.518 2.518
202106 2.193 108.486 2.551
202109 2.000 109.435 2.306
202112 2.357 110.384 2.695
202203 2.398 113.968 2.655
202206 2.759 115.760 3.008
202209 2.803 118.818 2.977
202212 2.721 119.345 2.877
202303 2.778 122.402 2.864
202306 2.878 123.140 2.949
202309 3.160 124.195 3.211
202312 2.989 123.773 3.048
202403 3.244 125.038 3.274
202406 3.729 125.882 3.738
202409 3.362 126.198 3.362

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Eckert & Ziegler SE  (XTER:EUZ) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Eckert & Ziegler SE's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=48.24/10.01
=4.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Eckert & Ziegler SE was 16.97. The lowest was 1.23. And the median was 4.33.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Eckert & Ziegler SE Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Eckert & Ziegler SE Business Description

Traded in Other Exchanges
Address
Robert-Rossle-Street 10, Berlin, BB, DEU, 13125
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.
Executives
Dr. Andreas Eckert Supervisory Board
Frank Perschmann Supervisory Board
Dr. Hakim Bouterfa Board of Directors
Prof. Dr. Wolfgang Maennig Supervisory Board
Dr. Harald Hasselmann Board of Directors

Eckert & Ziegler SE Headlines

No Headlines